InsiderClue
Stocks · Health care · Pharmaceutical Preparations

BridgeBio Pharma, Inc.

BBIO Clue Score39
United States Fiscal year ends December CIK 0001743881 Results filed 29 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

17
Insider
Date
Role
Action
Shares
Price
Amount
Andrew Lo
18 Nov 2025
Director
Sell indirect
30,993
$66.05
$2.05M
Andrew Lo
18 Nov 2025
Director
Sell indirect
24,007
$65.23
$1.57M
Andrew Lo
17 Nov 2025
Director
Sell
3,798
$67.06
$254.68K
Andrew Lo
17 Nov 2025
Director
Sell
36,801
$66.63
$2.45M
Thomas Trimarchi
21 Aug 2025
President and CFO
Sell
42,237
$49.48
$2.09M
Maricel Apuli
7 Aug 2025
Chief Accounting Officer
Sell
1,000
$45.44
$45.44K
Viking Global Investors LP
27 Jun 2025
10% owner
Sell indirect
3,500,000
$44.00
$154.00M
Hannah Valantine
26 Jun 2025
Director
Sell indirect
1,891
$44.03
$83.26K
Hannah Valantine
26 Jun 2025
Director
Sell indirect
398
$44.13
$17.56K
Hannah Valantine
26 Jun 2025
Director
Sell
1,542
$44.01
$67.86K
Hannah Valantine
26 Jun 2025
Director
Sell
876
$44.11
$38.64K
KKR Genetic Disorder L.P.
12 May 2025
10% owner
Sell indirect
6,000,000
$34.20
$205.20M
Andrew Lo
2 May 2025
Director
Sell indirect
100,000
$38.50
$3.85M
Maricel Apuli
2 May 2025
Chief Accounting Officer
Sell
1,026
$38.51
$39.51K
KKR Genetic Disorder L.P.
5 Mar 2025
10% owner
Sell indirect
6,000,000
$32.96
$197.76M
Viking Global Investors LP
31 Jan 2025
10% owner
Sell indirect
3,065,616
$34.90
$106.99M
KKR Genetic Disorder L.P.
13 Sep 2024
10% owner
Sell indirect
5,800,000
$25.75
$149.35M
Showing 250 of 457 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 402
Amendments (4/A) skipped 5
Filings about a different issuer 8
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 212
Sales straight out of an exercise 73
Sales at will 146
Transactions with no price 1
Shares from compensation/vesting 141,557,600
Sales filed before the plan box existed 128
History held since 26 Jun 2018